Top Markets
Coin of the day
Jenscare Scientific Co., Ltd. Jenscare Scientific Co., Ltd.

Jenscare Scientific Co., Ltd.

9877
Rangering i aksjer #15055
Jenscare Scientific Co., Ltd. operates as a medical technology enterprise... Jenscare Scientific Co., Ltd. operates as a medical technology enterprise dedicated to advancing interventional therapies for structural heart conditions within the People's Republic of China. Among its pipeline, the company features LuX-Valve, an investigational transcatheter tricuspid valve replacement (TTVR) system designed for patients suffering from severe tricuspid regurgitation who face elevated surgical risks. Additionally, Ken-Valve represents another key product candidate, a transcatheter aortic valve replacement (TAVR) aimed at addressing severe aortic regurgitation, often co-occurring with aortic stenosis. The applications of Jenscare's portfolio extend to a range of structural cardiac maladies, including disorders of the tricuspid, aortic, and mitral valves, as well as heart failure. Founded in 2011, the company maintains its principal place of business in Ningbo, People's Republic of China.
Aksjekurs
$0.90187992
Markedsverdi
$376.23M
Endring (1 dag)
-2.69%
Endring (1 år)
-14.56%
Land
CN
Handel Jenscare Scientific Co., Ltd. (9877)

Kategori

Inntekter for Jenscare Scientific Co., Ltd. (9877)
Inntekter i 2026 TTM: 0
Ifølge Jenscare Scientific Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Jenscare Scientific Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter